Insperity Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw strong adjusted EPS and EBITDA growth, driven by margin recovery, disciplined expense management, and successful launch of Insperity HRScale. Full-year guidance was raised, with continued focus on margin recovery, sales momentum, and managing healthcare cost risks.
-
Q1 2026 saw Adjusted EPS fall 17% year-over-year to $1.31, while Adjusted EBITDA rose 1% to $103 million, both above guidance midpoints. Margin recovery is ahead of schedule, but worksite employee growth is revised downward due to macroeconomic headwinds and higher attrition. HRScale rollout and AI initiatives are progressing, with strong client interest.
Fiscal Year 2025
-
Q4 2025 results reflected ongoing macro and healthcare cost headwinds, with adjusted EPS at -$0.60 and adjusted EBITDA at -$13M. 2026 guidance anticipates margin recovery, lower operating expenses, and the HRScale rollout, with adjusted EBITDA forecasted to rise 30%-76%.
-
Q3 2025 results were impacted by a sharp rise in healthcare claims, leading to lower-than-expected earnings despite strong client retention and sales momentum. Strategic pricing, a new UHC contract, and the HRScale rollout are expected to drive a rebound in 2026.
-
Q2 2025 results were slightly below guidance due to higher benefits costs, but worksite employee growth and sales efficiency improved. Management raised full-year benefits cost guidance and remains focused on pricing, plan design, and expense management to drive profitability in 2026, with the Workday partnership and new HR solutions expected to support future growth.
-
Q1 results missed guidance due to higher benefits costs and delayed client starts amid economic uncertainty. Client retention and sales activity were strong, but 2025 growth guidance was trimmed. The Workday partnership achieved key milestones, with a new joint solution expected to drive future growth.
Fiscal Year 2024
-
Q4 2024 results exceeded guidance with strong client retention and sales momentum, despite weak client hiring. The Workday partnership advanced with key milestones ahead, and 2025 guidance anticipates modest growth, continued investment, and stable operating expenses.
-
Q3 2024 saw solid Adjusted EPS and EBITDA despite a 2% decline in paid worksite employees, with strong client retention and disciplined pricing offsetting weak hiring. Full-year guidance was narrowed to the lower end, and significant investments continue in AI and the Workday partnership.
-
Q2 2024 saw strong financial outperformance, with adjusted EPS up 34% and EBITDA up 29% year-over-year, driven by strong pricing and lower benefit costs. Despite a 1% decline in paid worksite employees and ongoing SMB market challenges, client retention remained high and the Workday partnership advanced on schedule.